Is LGVN or LNAI more undervalued in 2026?

CirclFi compares Longeveron Inc. (LGVN) and Lunai Bioworks Inc. (LNAI) using 13 institutional-grade valuation models. LGVN has a Quality of Company score of 5.8/10 while LNAI scores 2.9/10.

Which is a better buy — LGVN or LNAI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do LGVN and LNAI valuations compare?

LGVN at $0.77 and LNAI at $3.08 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

LGVN vs LNAI Valuation Comparison 2026 — Intrinsic Value Analysis

LGVN

Pharmaceutical Preparations

Longeveron Inc.

Quality

5.8

out of 10

Value Trap

LOW

Price

$0.77

Last close

Models

11/13

Active

LNAI

Pharmaceutical Preparations

Lunai Bioworks Inc.

Quality

2.9

out of 10

Value Trap

WARN

Price

$3.08

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	LGVN Fair Value	LGVN Upside	LNAI Fair Value	LNAI Upside
Bayesian DCF	Intrinsic	$0.46	-40.7%	$0.06	-97.9%
Earnings Power Value	Intrinsic	$0.39	-58.1%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$0.82	+5.9%	$0.65	-78.8%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for LGVN vs LNAI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LGVN vs LNAI — Which Stock Is More Undervalued?

LGVN scores higher with a 5.8/10 quality rating vs LNAI's 2.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Longeveron Inc. (LGVN) and Lunai Bioworks Inc. (LNAI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LGVN currently trades at $0.77 with a QOC of 5.8/10, while LNAI trades at $3.08 with a QOC of 2.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).